1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on November 5, 2025

Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings
AMGN

MT Newswires

21 hours ago

Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week
AMGN

The Wall Street Journal

a day ago

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

AMGN

Argus Research

2 days ago

Market Digest: FHI, IEX, MCO, ORLY, UTHR, VLO, META, MDLZ

AMGN

MT Newswires

2 days ago

US Equity Investors to Focus on Earnings This Week as Government Shutdown Set to Become Longest in History

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week
AMGN

The Wall Street Journal

2 days ago

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

Amgen Earnings: What To Look For From AMGN
AMGN

StockStory

2 days ago

Amgen Earnings: What To Look For From AMGN

The Bull Case For Royalty Pharma (RPRX) Could Change Following $2 Billion Debt Raise and New Royalty Deals
AMGN

Simply Wall St.

3 days ago

The Bull Case For Royalty Pharma (RPRX) Could Change Following $2 Billion Debt Raise and New Royalty Deals

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week
AMGN

Yahoo Finance

3 days ago

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week

A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases
AMGN

Simply Wall St.

3 days ago

A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases

Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation
AMGN

Simply Wall St.

4 days ago

Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation

SNAP benefits expire, open enrollment, earnings: What to Watch
AMGN

Yahoo Finance Video

4 days ago

SNAP benefits expire, open enrollment, earnings: What to Watch

AMGN

MT Newswires

5 days ago

S&P 500 Advances Weekly Amid Gains in Information Technology, Consumer Discretionary

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
AMGN

PR Newswire

5 days ago

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND

Agilent selects Adam Elinoff as CFO
AMGN

MedTech Dive

5 days ago

Agilent selects Adam Elinoff as CFO

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
AMGN

Zacks

5 days ago

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
AMGN

PR Newswire

5 days ago

AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

Amgen Stock: Analyst Estimates & Ratings
AMGN

Barchart

5 days ago

Amgen Stock: Analyst Estimates & Ratings

CFOs On the Move: Week ending Oct. 31
AMGN

CFO.com

5 days ago

CFOs On the Move: Week ending Oct. 31

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
AMGN

Zacks

6 days ago

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Insiders At Amgen Sold US$12m In Stock, Alluding To Potential Weakness
AMGN

Simply Wall St.

6 days ago

Insiders At Amgen Sold US$12m In Stock, Alluding To Potential Weakness

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
AMGN

PR Newswire

7 days ago

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS

Trump Administration Eases Approval Process for Biosimilar Drugs
AMGN

Barrons.com

7 days ago

Trump Administration Eases Approval Process for Biosimilar Drugs

Amgen's Q3 Earnings in the Cards: Here's What to Expect
AMGN

Zacks

7 days ago

Amgen's Q3 Earnings in the Cards: Here's What to Expect

Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for
AMGN

Zacks

7 days ago

Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain
AMGN

24/7 Wall St.

8 days ago

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline
AMGN

Zacks

8 days ago

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline

Agilent Technologies Names Adam S. Elinoff as CFO
AMGN

Exec Edge

8 days ago

Agilent Technologies Names Adam S. Elinoff as CFO

AMGN

MT Newswires

8 days ago

Agilent Technologies Appoints Adam Elinoff as CFO

Agilent Names Adam S. Elinoff as Chief Financial Officer
AMGN

Business Wire

9 days ago

Agilent Names Adam S. Elinoff as Chief Financial Officer

2 Value Stocks on Our Watchlist and 1 Facing Headwinds
AMGN

StockStory

9 days ago

2 Value Stocks on Our Watchlist and 1 Facing Headwinds

Is Amgen Riding the Momentum After a 6.9% Price Jump?
AMGN

Simply Wall St.

10 days ago

Is Amgen Riding the Momentum After a 6.9% Price Jump?

The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market
AMGN

Zacks

12 days ago

The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market

1 Top Dividend Growth Stock to Buy Right Now
AMGN

Motley Fool

12 days ago

1 Top Dividend Growth Stock to Buy Right Now

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
AMGN

Zacks

12 days ago

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Top Research Reports for Amazon.com, Wells Fargo & Amgen
AMGN

Zacks

13 days ago

Top Research Reports for Amazon.com, Wells Fargo & Amgen

Why Amgen (AMGN) Dipped More Than Broader Market Today
AMGN

Zacks

13 days ago

Why Amgen (AMGN) Dipped More Than Broader Market Today

2 Reasons to Like AMGN and 1 to Stay Skeptical
AMGN

StockStory

16 days ago

2 Reasons to Like AMGN and 1 to Stay Skeptical

AMGN

MT Newswires

19 days ago

Amgen, AstraZeneca Say FDA Approves Tezspire for Chronic Rhinosinusitis

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
AMGN

PR Newswire

19 days ago

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics
AMGN

Zacks

19 days ago

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics

A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism
AMGN

Simply Wall St.

20 days ago

A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism

Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly
AMGN

Simply Wall St.

20 days ago

Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly

Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study
AMGN

Insider Monkey

20 days ago

Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study

Amgen (AMGN) Laps the Stock Market: Here's Why
AMGN

Zacks

20 days ago

Amgen (AMGN) Laps the Stock Market: Here's Why

Amgen (AMGN) Announces Launch of AmgenNow
AMGN

Insider Monkey

22 days ago

Amgen (AMGN) Announces Launch of AmgenNow

Why Amgen (AMGN) Could Beat Earnings Estimates Again
AMGN

Zacks

23 days ago

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention
AMGN

Insider Monkey

23 days ago

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN)
AMGN

StockStory

23 days ago

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN)

With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing
AMGN

Simply Wall St.

24 days ago

With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing

Here's What to Expect From Amgen’s Next Earnings Report
AMGN

Barchart

a month ago

Here's What to Expect From Amgen’s Next Earnings Report

What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push.
AMGN

Barrons.com

a month ago

What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push.

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab
AMGN

GlobeNewswire

a month ago

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
AMGN

Zacks

a month ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges
AMGN

StockStory

a month ago

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?
AMGN

Simply Wall St.

a month ago

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%
AMGN

Zacks

a month ago

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

/C O R R E C T I O N -- Amgen/
AMGN

PR Newswire

a month ago

/C O R R E C T I O N -- Amgen/

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
AMGN

Zacks

a month ago

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online
AMGN

GuruFocus.com

a month ago

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts
AMGN

The Wall Street Journal

a month ago

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

AMGN

MT Newswires

a month ago

GoodRx Expands Affordable Access to Cholesterol Drug Repatha

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035
AMGN

GlobeNewswire

a month ago

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

AMGN

MT Newswires

a month ago

Amgen Introduces Direct-to-Patient Access for Repatha in US

Here's Why Amgen (AMGN) is a Strong Value Stock
AMGN

Zacks

a month ago

Here's Why Amgen (AMGN) is a Strong Value Stock

4 Reasons to Buy Amgen Stock Right Now
AMGN

Motley Fool

a month ago

4 Reasons to Buy Amgen Stock Right Now

Amgen’s Phase III data supports FDA label expansion of Repatha
AMGN

Clinical Trials Arena

a month ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Amgen’s Phase III data supports FDA label expansion of Repatha
AMGN

Pharmaceutical Technology

a month ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial
AMGN

Clinical Trials Arena

a month ago

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial

September in Review: 11 Top Health Press Releases
AMGN

PR Newswire

a month ago

September in Review: 11 Top Health Press Releases

AMGN

Argus Research

a month ago

Analyst Report: Regeneron Phars, Inc

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise
AMGN

Simply Wall St.

a month ago

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise

AMGN

MT Newswires

a month ago

Amgen Says Dual Primary Endpoints Met in Phase 3 Cardiovascular Events Prevention Trial of Repatha

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
AMGN

Zacks

a month ago

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen
AMGN

StockStory

a month ago

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
AMGN

PR Newswire

a month ago

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done
AMGN

Investor's Business Daily

a month ago

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
AMGN

Motley Fool

a month ago

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs
AMGN

Insider Monkey

a month ago

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion
AMGN

Insider Monkey

a month ago

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion

AMGN

Morningstar Research

a month ago

Analyst Report: Amgen Inc.

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks
AMGN

Benzinga

a month ago

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown
AMGN

MT Newswires

a month ago

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi
AMGN

GlobeNewswire

a month ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff
AMGN

Investor's Business Daily

a month ago

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff

Immatics Appoints Venkat Ramanan as Chief Financial Officer
AMGN

GlobeNewswire

a month ago

Immatics Appoints Venkat Ramanan as Chief Financial Officer

AMGN

MT Newswires

a month ago

Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.
AMGN

Barrons.com

a month ago

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
AMGN

StockStory

a month ago

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)
AMGN

Insider Monkey

a month ago

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)

Amgen to expand US drug production with $650M investment
AMGN

Manufacturing Dive

a month ago

Amgen to expand US drug production with $650M investment

Amgen to invest $650m in US manufacturing network expansion
AMGN

Pharmaceutical Technology

a month ago

Amgen to invest $650m in US manufacturing network expansion

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency
AMGN

Insider Monkey

a month ago

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs
AMGN

Insider Monkey

a month ago

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)
AMGN

Simply Wall St.

a month ago

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)

GLP-1 race evolves as Amgen & weight-loss pills enter the scene
AMGN

Yahoo Finance Video

a month ago

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.
AMGN

Barrons.com

a month ago

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
AMGN

Fortune

a month ago

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More
AMGN

Barrons.com

a month ago

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

AMGN

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain Late Afternoon

AMGN

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Share on Social Networks: